Jessie Xu is a Partner in the Corporate team of our Shanghai office. She provides comprehensive legal services for various offshore transactions, covering initial public offerings and secondary offerings (including listings of SPACs), mergers and acquisitions involving both private and listed companies (including privatisation deals and De-SPAC transactions), joint ventures, equity financing, banking and finance, group restructuring, funds, and trusts. She has handled numerous high-end cross-border transactions across diverse sectors such as biopharmaceuticals, artificial intelligence, communications, education, telecommunications and m
...Jessie Xu is a Partner in the Corporate team of our Shanghai office. She provides comprehensive legal services for various offshore transactions, covering initial public offerings and secondary offerings (including listings of SPACs), mergers and acquisitions involving both private and listed companies (including privatisation deals and De-SPAC transactions), joint ventures, equity financing, banking and finance, group restructuring, funds, and trusts. She has handled numerous high-end cross-border transactions across diverse sectors such as biopharmaceuticals, artificial intelligence, communications, education, telecommunications and media, energy, infrastructure, and real estate.
As the lead Partner, Jessie has spearheaded several significant offshore listing projects, including: the successful listing of China Resources Beverage (Holding) Company Ltd. on the main board of the Hong Kong Stock Exchange, which was awarded the "Deal of the Year 2024" by China Business Law Journal and was shortlisted for the "Equity Market Deal of the Year" at the ALB China Law Awards 2025; representing AstraZeneca in its acquisition of Gracell Biotechnologies, which won the "Deal of the Year 2024" by China Business Law Journal and the "M&A Deal of the Year" at the ALB China Law Awards 2024; and representing Xpeng Inc. in the listing of its Class A ordinary shares in the form of ADRs on the New York Stock Exchange, which was awarded the "Deal of the Year 2020" by China Business Law Journal.
Among the honours Jessie has received are: The "A - List: Rising Stars" of China Business Law Journal, CBLJ, "Prominent Legal Practitioners (Capital Markets) at the 2025 LegalOne Yangtze River Delta Law Awards", "ALB Offshore Client Choice 2025" and "ALB China Top 15 Rising Lawyers in 2023".
Prior to joining Harneys in 2017, Jessie practised as a Chinese-qualified attorney at Jun He’s Shanghai office. Subsequently, she served as a registered foreign lawyer (New York, USA) at Clifford Chance’s Hong Kong office.
Jessie does not currently provide services involving legal opinions on PRC law. She is fluent in Mandarin and English.
